市场立即捐赠成为会员

购物车 (0)

DIA会员及用户请点击登录

登录

忘记用户 ID？ or 忘记密码？

Not a Member?

创建账户并加入。

Renaissance Glendale Hotel and Spa

2015 年 03 月 16 日 1:00 下午 - 2015 年 03 月 18 日 4:30 下午

9495 W. Coyotes Boulevard, Glendale, AZ 85305

Medical & Scientific Communications 2015 Annual Forum

返回 Agenda

Session 6 Track A: Medical Communications in the Evolving Payer Landscape: Demonstrating Product Value and Outcomes to Payers

Session Chair(s)

Julia Petses, PHARMD

Julia Petses, PHARMD

Global Head, Medical Information Excellence and SEC Established and Rare Franchi

Novartis, United States

The US health care system has been evolving over time and recently underwent a large transformation due to the Affordable Care Act. It has moved away from fee-for service, volume based care and moved toward pay-for-performance and value-based care. The intent is to maximize value for patients by improving quality of care and achieving the best outcomes at the lowest cost. As the health care landscape has changed to a value-based model, the medical information needs of payers (i.e., private insurance, Center for Medicare and Medicaid Services, healthcare systems, accountable care organizations, etc.) have changed to require information beyond the AMCP dossier. Medical communications departments will need to understand what the informational needs are for different payers, how to partner with them to generate and compile relevant data, and how to deliver it most effectively. This interactive session will provide medical information, health outcomes liaison and payer perspectives on fulfilling the medical information needs of this customer type.

Learning Objective : At the conclusion of this session, participants should be able to:
• Describe different types of medical information created specifically for payers and formulary decision makers
• Explain the role of outcomes liaisons including and how they partner with customers to generate health outcomes data
• Discuss ways to effectively present product value to a payer

Speaker(s)

Faculty

Eleonora Ford, PHD

Amgen Inc., United States

Global Regulatory Affairs and R&D Policy

Faculty

Thu-Mai Duong

Sanofi US, United States

Regional Outcomes Liaison

Faculty

Scott R. Taylor, MBA, RPH

Geisenger Health Systems, United States

Executive Director, Industry Relations